Carie Boyd Pharmaceuticals specializes in compounding a diverse range of office-use and patient-specific medications. With a 503B outsourcing facility and 503A specialty compounding pharmacy, we are able to address nearly all the compounding needs of healthcare providers and their patients.

Founded in 1965 as a local community pharmacy, our journey began by collaborating with general practitioners, urologists, and OB-GYNs in the Dallas-Ft. Worth area. As our expertise in hormones began to draw more attention, we quickly expanded and started supplying medications to healthcare providers in neighboring states. By 2012, we had emerged as a leading supplier of implantable subcutaneous hormone pellets, which quickly made us a sought after compounding partner for providers from coast to coast.

In 2015, we became one of the first to register a facility with the FDA as a 503B outsourcing facility. Our outsourcing facility enabled us to fulfill bulk orders of compounded medications without any prescriptions, keep compounded medications in inventory so that we could quickly fulfill orders, and help healthcare providers and healthcare systems ensure that they have stable, consistent, and immediately-available supplies of important medications.

Today, Carie Boyd Pharmaceuticals is a recognized industry leader that is continuously seeking opportunities to support our customers and their patients. We are dedicated to supplying patients and the broader healthcare system with the highest-quality compounded medications, unparalleled service, and innovative solutions. Our goal is to provide our customers with unique medications quickly, easily, and consistently.